+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gamma Knife Market by Distribution Channel, End User, Application, Product Type - Global Forecast to 2030- Product Image
Gamma Knife Market by Distribution Channel, End User, Application, Product Type - Global Forecast to 2030- Product Image
Sale

Gamma Knife Market by Distribution Channel, End User, Application, Product Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666137
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gamma Knife Market grew from USD 374.91 million in 2024 to USD 401.05 million in 2025. It is expected to continue growing at a CAGR of 6.91%, reaching USD 560.02 million by 2030.

Unveiling the Future of High-Precision Radiosurgery

The Gamma Knife delivers unparalleled precision in treating deep-seated brain disorders with minimal collateral damage. As a cornerstone of stereotactic radiosurgery, it has transformed neurosurgical protocols and offered new hope for patients with complex neurological conditions. This executive summary unpacks the critical factors shaping current and future trajectories of the Gamma Knife market. From evolving clinical applications to shifting regulatory frameworks, it provides a holistic overview that bridges technological breakthroughs with real-world adoption dynamics.

By synthesizing the latest trends in device innovation, patient demographics, and health-economics drivers, this introduction sets the stage for a deeper exploration of market opportunities and challenges. It frames the narrative around how stakeholders-from device manufacturers to healthcare providers-are navigating an environment characterized by rapid evolution. This section also outlines the methodology employed to gather and validate insights, ensuring that decision-makers can trust the rigor underpinning the analysis. Ultimately, the introduction clarifies the scope and objectives of the report, guiding readers through a structured journey of discovery and strategic foresight.

Evolving Paradigms in Radiosurgical Innovation and Adoption

In recent years, Gamma Knife technology has transcended its origins as a niche neurosurgical tool to become a mainstream modality in treating a spectrum of brain pathologies. Technological advancements such as integrated imaging platforms and AI-driven treatment planning have accelerated procedure accuracy and shortened patient preparation times. Concurrently, an increasing emphasis on outpatient-based care has prompted ambulatory surgical centers to adopt Gamma Knife units, challenging the traditional hospital-centric delivery model.

Regulatory bodies are also reshaping the landscape by streamlining approval pathways for incremental device enhancements, enabling faster time-to-market for next-generation systems. This shift has empowered manufacturers to iterate on product designs more frequently, introducing features like enhanced beam collimators and adaptive dose algorithms. Moreover, collaborative initiatives between device makers and clinical research institutes have spurred new applications, notably in functional disorders and vascular malformations. These transformative shifts are forging a market environment where innovation cycles are compressing and clinical utility is expanding, driving both competitive intensity and broader patient access.

Analyzing the 2025 US Tariffs and Their Influence on Market Dynamics

The introduction of new tariff measures in the United States as of 2025 has injected both uncertainty and strategic recalibration across the Gamma Knife value chain. Import duties on key components and finished systems have elevated manufacturing costs for overseas producers, prompting adjustments in pricing models and contract structures. Equipment distributors and OEM sales teams are negotiating revised terms to mitigate margin compression, while local production facilities are being evaluated as a hedge against tariff exposure.

Supply chain managers are also diversifying sourcing strategies, seeking alternative suppliers for critical subsystems and exploring nearshoring opportunities to reduce lead times. Clinical customers face potential procurement delays and increased maintenance expenses, which in turn influence capital expenditure cycles. Amid these headwinds, some vendors are offering bundled service packages and extended warranty programs to preserve customer loyalty. As a result, the tariff landscape has catalyzed a reconfiguration of channel dynamics, underscoring the importance of flexible go-to-market approaches and resilient operational frameworks.

Deciphering Market Segmentation to Uncover Growth Pathways

Decoding market segments reveals nuanced demand patterns that can guide strategic prioritization. Across distribution channels, the landscape is split between direct sales, which funnel systems through e-commerce platforms and dedicated OEM sales teams, and distributor networks differentiated by local operators or national distributors covering broader territories. End-user segmentation highlights the contrasting purchasing behaviors of ambulatory surgical centers, where radiology-focused and surgical-oriented units have distinct workflow requirements, alongside hospitals that range from community institutions to tertiary care centers offering advanced neurosurgical services, as well as specialty clinics in neurosurgery and oncology that demand targeted therapeutic capabilities.

Application-based analysis further refines opportunity mapping, distinguishing between brain tumor interventions-where metastatic cases typically drive higher throughput compared to primary tumor treatments-and functional disorder applications, including movement disorder management and trigeminal neuralgia ablation, which rely on specialized dose protocols. Vascular malformations, spanning arteriovenous malformations and cavernous malformations, represent another key use case with dedicated clinical pathways. Finally, product-type segmentation encompasses the established 4C platform, the versatile Icon series, the Model C lineage, and the state-of-the-art Perfexion system, each available as new unit acquisitions or upgrade packages for existing installations. This intricate segmentation framework illuminates where targeted investments, marketing efforts, and service offerings can yield the greatest return.

Regional Perspectives Shaping Market Expansion

Regional dynamics influence both adoption rates and competitive positioning. In the Americas, robust healthcare infrastructure, favorable reimbursement policies, and high patient awareness contribute to an established market with incremental growth driven by system upgrades and extended maintenance agreements. Contrastingly, Europe, the Middle East, and Africa exhibit varied adoption patterns, shaped by heterogeneous regulatory environments and funding mechanisms that range from centralized public procurement in some European nations to private sector-led expansions in parts of the Middle East.

Meanwhile, Asia-Pacific presents a dual landscape of mature markets such as Japan and Australia, where innovation adoption mirrors Western trends, and rapidly evolving regions including China and India, where increasing healthcare investments and rising neurological disorder prevalence are fueling new installations. These regional insights underscore the importance of tailored market entry strategies, local partnerships, and adaptable pricing models to address divergent customer expectations and resource constraints.

Competitive Landscape Spotlight on Leading Manufacturers

Leading manufacturers are leveraging differentiated strategies to sustain competitive advantage. Legacy innovators continue to invest in R&D, refining beam delivery mechanisms and enhancing user interfaces to streamline clinical workflows. They complement product innovation with comprehensive service portfolios, including remote monitoring, predictive maintenance, and training programs designed to optimize utilization rates. Emerging players are forging alliances with technology firms specializing in AI and imaging, aiming to introduce adjunct software solutions that offer competitive differentiation.

Strategic collaborations with academic institutions and participation in clinical trials serve as platforms for validating new applications and broadening the evidence base. Channel diversification is another focal point, as original equipment manufacturers seek to strengthen relationships with both direct hospital procurement teams and independent distributors across key territories. Mergers and acquisitions activity has also intensified, with established players seeking to acquire niche specialists or add complementary modalities, thereby expanding addressable markets and deepening service engagement across the customer lifecycle.

Strategic Imperatives to Capitalize on Emerging Trends

Leaders in the Gamma Knife sector should adopt a multi-pronged approach to capitalize on emerging trends. First, optimizing supply chains through strategic nearshoring and dual-sourcing can mitigate tariff-induced disruptions and uphold delivery reliability. Second, embedding AI-driven treatment planning and image-guided workflows into core offerings will strengthen clinical value propositions and differentiate systems in procurement negotiations. Third, cultivating partnerships with specialized ambulatory centers and academic hospitals can accelerate adoption in niche therapy segments, such as trigeminal neuralgia and arteriovenous malformation ablation.

Furthermore, aligning upgrade programs with service contracts will unlock recurring revenue streams and deepen customer relationships. Tailoring regional go-to-market models-by forging local distributor alliances in complex regulatory environments and deploying direct sales in high-margin territories-will enhance market penetration. Finally, committing to continuous educational initiatives aimed at both clinical teams and administrative executives can elevate institutional readiness for technology adoption, ensuring that investment decisions reflect the full spectrum of clinical efficacy, operational efficiency, and patient outcomes.

Robust Methodology Underpinning the Market Analysis

This analysis integrates a rigorous mixed-methods approach, commencing with an exhaustive review of public scientific literature, regulatory filings, and patent databases to map the technological trajectory of Gamma Knife systems. Expert interviews with neurosurgeons, medical physicists, healthcare executives, and supply chain specialists provided qualitative insights into clinical adoption barriers, operational constraints, and strategic priorities. Complementary secondary research encompassed corporate financial reports, industry whitepapers, and regional reimbursement guidelines to capture economic drivers and policy influences.

Data triangulation ensured that quantitative and qualitative inputs were aligned, enhancing the robustness of trend identification and impact assessment. Geospatial analysis of installed base densities and procedure volumes informed regional market sizing without relying on speculative forecasts. Finally, validation workshops with independent key opinion leaders were conducted to refine assumptions, challenge preliminary findings, and ensure actionable relevance for decision-makers.

Converging Insights to Navigate the Market Landscape

The confluence of technological innovation, shifting reimbursement landscapes, and strategic realignments driven by tariffs has created an inflection point for the Gamma Knife market. Precision enhancements and expanded clinical applications are unlocking new avenues for patient care, while regional disparities and trade dynamics necessitate adaptable business models. Manufacturers and providers alike must navigate this complex environment with agility and foresight, leveraging detailed segmentation insights and competitive intelligence to guide investment decisions.

By synthesizing cross-sectional data and expert perspectives, this report equips stakeholders with the strategic clarity needed to prioritize growth initiatives, optimize resource allocation, and forge enduring partnerships. The convergence of insights presented herein underscores the critical importance of aligning technological capabilities with market realities, ensuring that the promise of high-precision radiosurgery continues to translate into improved patient outcomes and sustainable commercial success.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Distribution Channel
    • Direct Sales
      • E Commerce
      • Oem Sales Team
    • Distributor
      • Local Distributors
      • National Distributors
  • End User
    • Ambulatory Surgical Centers
      • Radiology Centers
      • Surgical Centers
    • Hospitals
      • Community Hospitals
      • Tertiary Care Hospitals
    • Specialty Clinics
      • Neurosurgery Centers
      • Oncology Clinics
  • Application
    • Brain Tumors
      • Metastatic Brain Tumors
      • Primary Brain Tumors
    • Functional Disorders
      • Movement Disorders
      • Trigeminal Neuralgia
    • Vascular Malformations
      • Arteriovenous Malformations
      • Cavernous Malformations
  • Product Type
    • 4C
      • New Units
      • Upgrades
    • Icon
      • New Units
      • Upgrades
    • Model C
      • New Units
      • Upgrades
    • Perfexion
      • New Units
      • Upgrades
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Elekta AB (publ)
  • Accuray Incorporated
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • Brainlab AG
  • ViewRay, Inc.
  • Nordion Inc.
  • Mevion Medical Systems, Inc.
  • IBA Group S.A.
  • Shinva Medical Instrument Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gamma Knife Market, by Distribution Channel
8.1. Introduction
8.2. Direct Sales
8.2.1. E Commerce
8.2.2. Oem Sales Team
8.3. Distributor
8.3.1. Local Distributors
8.3.2. National Distributors
9. Gamma Knife Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.2.1. Radiology Centers
9.2.2. Surgical Centers
9.3. Hospitals
9.3.1. Community Hospitals
9.3.2. Tertiary Care Hospitals
9.4. Specialty Clinics
9.4.1. Neurosurgery Centers
9.4.2. Oncology Clinics
10. Gamma Knife Market, by Application
10.1. Introduction
10.2. Brain Tumors
10.2.1. Metastatic Brain Tumors
10.2.2. Primary Brain Tumors
10.3. Functional Disorders
10.3.1. Movement Disorders
10.3.2. Trigeminal Neuralgia
10.4. Vascular Malformations
10.4.1. Arteriovenous Malformations
10.4.2. Cavernous Malformations
11. Gamma Knife Market, by Product Type
11.1. Introduction
11.2. 4C
11.2.1. New Units
11.2.2. Upgrades
11.3. Icon
11.3.1. New Units
11.3.2. Upgrades
11.4. Model C
11.4.1. New Units
11.4.2. Upgrades
11.5. Perfexion
11.5.1. New Units
11.5.2. Upgrades
12. Americas Gamma Knife Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gamma Knife Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gamma Knife Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Elekta AB (publ)
15.3.2. Accuray Incorporated
15.3.3. Siemens Healthineers AG
15.3.4. Varian Medical Systems, Inc.
15.3.5. Brainlab AG
15.3.6. ViewRay, Inc.
15.3.7. Nordion Inc.
15.3.8. Mevion Medical Systems, Inc.
15.3.9. IBA Group S.A.
15.3.10. Shinva Medical Instrument Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GAMMA KNIFE MARKET MULTI-CURRENCY
FIGURE 2. GAMMA KNIFE MARKET MULTI-LANGUAGE
FIGURE 3. GAMMA KNIFE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GAMMA KNIFE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GAMMA KNIFE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GAMMA KNIFE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GAMMA KNIFE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GAMMA KNIFE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES GAMMA KNIFE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. CANADA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. CANADA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 94. CANADA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 95. CANADA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. CANADA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 97. CANADA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. CANADA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 99. CANADA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CANADA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 101. CANADA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 102. CANADA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 103. CANADA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. CANADA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 105. CANADA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 106. CANADA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 107. CANADA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. MEXICO GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 111. MEXICO GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MEXICO GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 121. MEXICO GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 122. MEXICO GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 123. MEXICO GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 189. GERMANY GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. GERMANY GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 191. GERMANY GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 192. GERMANY GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. GERMANY GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. GERMANY GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 198. GERMANY GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 199. GERMANY GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 200. GERMANY GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 202. GERMANY GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 203. GERMANY GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 204. GERMANY GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. FRANCE GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 207. FRANCE GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 208. FRANCE GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. FRANCE GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 214. FRANCE GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 215. FRANCE GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. FRANCE GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 218. FRANCE GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 219. FRANCE GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 220. FRANCE GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 237. ITALY GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. ITALY GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 239. ITALY GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 240. ITALY GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ITALY GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 242. ITALY GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 243. ITALY GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 244. ITALY GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. ITALY GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 246. ITALY GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 247. ITALY GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 248. ITALY GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. ITALY GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 250. ITALY GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 251. ITALY GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 252. ITALY GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 253. SPAIN GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SPAIN GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 255. SPAIN GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 256. SPAIN GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SPAIN GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 258. SPAIN GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. SPAIN GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 260. SPAIN GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SPAIN GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 262. SPAIN GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 263. SPAIN GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 264. SPAIN GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. SPAIN GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 266. SPAIN GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 267. SPAIN GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 268. SPAIN GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 317. DENMARK GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. DENMARK GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 319. DENMARK GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 320. DENMARK GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. DENMARK GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 322. DENMARK GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 323. DENMARK GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 324. DENMARK GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. DENMARK GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 326. DENMARK GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 327. DENMARK GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 328. DENMARK GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. DENMARK GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 330. DENMARK GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 331. DENMARK GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 332. DENMARK GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 347. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 348. NETHERLANDS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 349. QATAR GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 350. QATAR GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 351. QATAR GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 352. QATAR GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 353. QATAR GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 354. QATAR GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 355. QATAR GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 356. QATAR GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 357. QATAR GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 358. QATAR GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 359. QATAR GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2030 (USD MILLION)
TABLE 360. QATAR GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 361. QATAR GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2030 (USD MILLION)
TABLE 362. QATAR GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2030 (USD MILLION)
TABLE 363. QATAR GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2030 (USD MILLION)
TABLE 364. QATAR GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2030 (USD MILLION)
TABLE 365. FINLAND GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 366. FINLAND GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 367. FINLAND GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 368. FINLAND GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 369. FINLAND GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 370. FINLAND GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2

Companies Mentioned

The companies profiled in this Gamma Knife market report include:
  • Elekta AB (publ)
  • Accuray Incorporated
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • Brainlab AG
  • ViewRay, Inc.
  • Nordion Inc.
  • Mevion Medical Systems, Inc.
  • IBA Group S.A.
  • Shinva Medical Instrument Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 401.05 Million
Forecasted Market Value ( USD ) by 2030 $ 560.02 Million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gamma Knife - Global Strategic Business Report - Product Image

Gamma Knife - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
The History of the Gamma Knife. Progress in Brain Research Volume 215 - Product Image

The History of the Gamma Knife. Progress in Brain Research Volume 215

  • Book
Recent Advances and Controversies in Gamma Knife Neurosurgery. Progress in Brain Research Volume 268 - Product Image

Recent Advances and Controversies in Gamma Knife Neurosurgery. Progress in Brain Research Volume 268

  • Book
Radiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 - Product Image

Radiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036

  • Report
  • Global
From
Brazil Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems - Product Image

Brazil Radiosurgery Systems Market Outlook to 2033 - Linear Accelerator Radiosurgery Systems and GammaKnife Radiosurgery Systems

  • Report
  • 22 Pages
  • Brazil
From

About the Gamma Knife Market

The Gamma Knife is a type of surgical device used to treat brain tumors and other neurological conditions. It is a non-invasive, radiation-based treatment that uses gamma rays to target and destroy cancerous cells. The Gamma Knife is a highly precise and effective treatment option, and is often used when traditional surgery is not an option. It is also used to treat conditions such as arteriovenous malformations, trigeminal neuralgia, and acoustic neuromas. The Gamma Knife market is a rapidly growing segment of the surgical device industry. It is a highly specialized market, with a focus on providing the most advanced and effective treatments for neurological conditions. The market is driven by the increasing demand for non-invasive treatments, as well as the need for more precise and targeted treatments. Some of the major companies in the Gamma Knife market include Elekta, Accuray, Brainlab, and Varian Medical Systems. These companies are leading the way in developing and providing the most advanced and effective treatments for neurological conditions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.